Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Post by Waco4505on Oct 09, 2020 1:00pm
165 Views
Post# 31696145

Ford news

Ford news
  • More testing options: Ensuring health professionals can provide more people with timely and convenient tests by expanding the methods for COVID-19 testing. Less invasive collection methods, such as throat, nasal swabbing, and saliva collection will now be used in addition to nasopharyngeal swabs to test for COVID-19. Three Ontario hospitals are offering saliva collection, with more assessment centres offering this option in the coming weeks. Our government continues to review innovative technologies, such as rapid and point of care tests, to ensure Ontarians have access to leading and faster testing options.

  • More testing capacity: Continuing to expand the capacity of the provincial lab network so more tests can be processed and testing targets can be achieved. This includes hiring more lab staff and professional staff and improving data quality through digitizing requisition forms and other automated features. As a first step, the province will increase testing capacity to conduct up to 50,000 daily tests.

<< Previous
Bullboard Posts
Next >>